2019 – Page 9 – Policy & Medicine

Small Companies Are Not Immune From Prosecution – The Case Of Life Spine, Inc.

Repackage Your CME Programs for MIPS Compliance

The Chaos Over Drug Compounding Continues As Judge Throws Out Convictions Of NECC Executives

Pelosi Draft Plan Would Allow Price Negotiations on Select Drugs

Opioid Case Tests The Boundaries Of Liability – Oklahoma, J&J And The “Mutant Poppy Strain”

HHS OIG Posts Findings Following Opioid Prescribing Review

Florida AHCA Submits Concept Paper to HHS

FDA Finalizes Revised Guidance on REMS Revisions and Modifications

Industry Reaction Mixed to FDA Draft Guidance on Real World Data and Evidence

CMS to Host Public Meeting to Address Opioid Epidemic